Patients with ascending or aortic arch disease combined with cardiac disease were sometimes encountered. We analyzed surgical outcome comparatively with patients undergoing concomitant cardiac operation or aortic grafting alone. Subjects were 90 patients, aged 63 years (range, 26-83 year), undergoing artificial graft replacement of ascending and aoric arch disease between August 1994 and December 2000. Concomitant surgery group (group C) consisted of 39 patients undergoing graft replacement concomitant with cardiac repairs. Concomitant cardiac procedures involved 23 aortic valve resuspension, 4 Bentall, 2 aortic valve replacement (AVR), 2 coronary artery bypass grafting (CABG), 2 CABG+resuspension, and 1 each AVR+CABG, Bentall+CABG, David, ventricular septal defect closure, pulmonary artery plasty. Graft replacement alone group (group A) consisted of 51 patients undergoing aortic graft interposition alone. Hospital mortality was 18% in Ggroup C and 9.8% in Group A (P=0.35). By multiple logistic regression analysis, age (P=0.013), concomitant cardiac operation (P=0.0079), and aortic rupture (P=0.0045) were found to be independent predictors of hospital deaths. No significant difference was observed in postoperative complications between two groups. There was no significant difference in actuarial survival between the graft replacement of ascending or aortic arch disease with-and without-cardiac repair (74±8% vs. 79±6% at 3 years, respectively). Concomitant procedure of ascending or aortic arch surgery and cardiac repair was conducted acceptably. Hospital morbidity and mid-term survival did not differ significantly between two groups.
View full abstract